Biomarker-based studies, such as those using BNP elevation, demonstrated that dose exposure (e.g., heart V20-30) correlated with early subacute cardiac stress and subsequent pericardial effusion, underscoring the potential for biomarkers to serve as early warning tools linked directly to dose parameters. The gene discussed is NPPB; the disease is pericardial effusion.